Asymchem

Founded in 1999, Asymchem (Stock Code: 002821.SZ) is a global integrated CDMO providing drug R&D and manufacturing for leading pharmaceutical and biotech companies, with a mission to drive smarter, greener and more cost-effective manufacturing to support clinical research and commercialization. The company operates eight manufacturing facilities offering solutions from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations and clinical research materials.